Research programme: macrocyclic peptide therapeutics - GyreOx
Alternative Names: gyrocyclesLatest Information Update: 28 Apr 2024
At a glance
- Originator Unknown
- Class Macrocyclic compounds; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for research development in Cancer in USA
- 18 Mar 2020 New profile created from 9287450
- 11 Mar 2020 Early research in Cancer in USA (unspecified route) before March 2020